SCHEMBL10913083

SCHEMBL10913083

NS(=O)(=O)c1nc2cc(-c3ccccc3C(=O)O)ccc2s1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 17/20 0.56
▸ CA1 P00915 8/20 0.54
▸ CA4 P22748 4/20 0.54
▸ CA12 O43570 3/20 0.54
▸ CA14 Q9ULX7 2/20 0.54
▸ CA7 P43166 2/20 0.54
▸ CA9 Q16790 2/20 0.46
▸ CA6 P23280 1/20 0.46
▸ CA5A P35218 1/20 0.46
▸ CA5B Q9Y2D0 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.43
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ LIPC P11150 1/20 0.41
▸ LIPG Q9Y5X9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11009374 0.75 KDM4E (0.51) ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL10914045 0.72 CA2 (0.56) CA2CA1CA4CA12CA14
SCHEMBL564235 0.72 CA2 (1.00) CA2CA1CA4CA12CA14
SCHEMBL1845570 0.72 FFAR1 (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL10984165 0.72 CA2 (0.59) CA2CA1CA4CA12CA14
SCHEMBL7933436 0.72 CA2 (0.82) CA2CA1CA4CA12CA14
SCHEMBL30297744 0.71 CA2 (1.00) CA2CA1CA4CA12CA14
SCHEMBL81178 0.71 CA2 (1.00) CA2CA1CA4CA12CA14
SCHEMBL10913446 0.71 CA2 (0.61) CA2CA1CA4CA12CA14
SCHEMBL6978903 0.70 CA2 (0.65) CA2CA1CA4CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0091367-B1 BENZOTHIAZOLESULFONAMIDE DERIVATIVES FOR THE TOPICAL TREATMENT OF ELEVATED INTRAOCULAR PRESSURE MERCK & CO. INC. (US) 1986-06-18 — — EP claimed
Send feedback